Granules India has informed that the Board of Directors of the Company at its meeting held on July 23, 2015, has approved the investment of up to Rs. 20 Crores in GIL Lifesciences, a wholly owned Indian Subsidiary of the Company, approved the issue of 1,86,56,000 warrants on preferential basis to Tyche Technologies, a promoter group Company, subject to approval of the members, at a price arrived at in accordance with the SEBI (ICDR) Regulations, 2009 and fixed the date of Extra-Ordinary General Meeting of the members of the Company on August 24, 2015 to consider the issue of warrants on preferential basis to Promoter Group Company.
The above information is a part of company’s filings submitted to BSE.
